New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
08:12 EDTPINC, HSPPremier acquires TheraDoc from Hospira for $117M
Premier (PINC) has reached a definitive agreement to acquire TheraDoc, a market leading provider of clinical surveillance software, for $117M in cash, subject to potential purchase price adjustments regarding TheraDoc's actual working capital, cash and indebtedness at closing. The transaction is expected to close in Premier's 1Q15 ending September 30. TheraDoc is a wholly-owned subsidiary of Hospira (HSP). Premier's board unanimously approved the transaction, and applicable antitrust approvals have already been obtained. Based on the trailing twelve months operating earnings provided by TheraDoc, the $117M represents a purchase price multiple in the 10-11 times range. Premier expects the acquisition to be accretive to earnings in the first year following the transaction's completion.
News For PINC;HSP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
08:04 EDTHSPGerman fund pressured to sell Mylan stake over drug used in executions, FT says
Subscribe for More Information
October 19, 2014
14:18 EDTHSPFresenius, others explore bid for Danone medical nutrition unit, Reuters says
Subscribe for More Information
October 14, 2014
11:23 EDTHSPBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
October 8, 2014
13:00 EDTHSPHospira recalling one lot of Vancomycin Hydrochloride
The FDA announced that Hospira is initiating a voluntary nationwide user-level recall of one lot of Vancomycin Hydrochloride. The action is because the product may have experienced temperature excursions during shipment to a customer and then was further distributed by the customer, the agency said. It added that there have been no adverse events or complaints reported for the affected lot. Hospira is "undertaking the recall out of an abundance of caution," the FDA said.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use